CSAD (cysteine sulfinic acid decarboxylase) is a pyridoxal-5'-phosphate (PLP)-dependent enzyme that primarily catalyzes the decarboxylation of cysteine sulfinic acid to hypotaurine, which is subsequently converted to taurine 1. This enzyme represents the rate-limiting step in mammalian taurine biosynthesis and is essential for maintaining cellular taurine homeostasis 2. CSAD exhibits highest expression during prenatal and early postnatal brain development and is found in both neurons and astrocytes 1. The enzyme's transcription is regulated by hepatocyte nuclear factor 4α (HNF4α) and is repressed by bile acid signaling through the FXR-SHP pathway, coupling hepatic taurine production to bile acid synthesis 3. Beyond its metabolic role, CSAD functions as an anti-inflammatory regulator by directly interacting with IKKα to inhibit excessive NF-κB signaling during viral infections 4. CSAD knockout mice demonstrate severe taurine deficiency, with neonatal mortality rates of 85% that can be rescued by maternal taurine supplementation 2. Disease relevance includes associations with fulminant type 1 diabetes susceptibility 5 and protection against alcohol-associated fatty liver disease through taurine-mediated lipid metabolism regulation 6.